BIICX | CAPFX | BIICX / CAPFX | |
Total Expense Ratio | 0.57 | 0.90 | 63% |
Annual Report Gross Expense Ratio | 0.68 | 1.10 | 62% |
Fund Existence | 18 years | 29 years | - |
Gain YTD | 10.216 | 9.605 | 106% |
Front Load | N/A | 1% | - |
Min. Initial Investment | 2000000 | 1500 | 133,333% |
Min. Initial Investment IRA | N/A | 250 | - |
Net Assets | 10.6B | 678M | 1,563% |
Annual Yield % from dividends | 5.72 | 3.39 | 169% |
Returns for 1 year | 8.84 | 9.39 | 94% |
Returns for 3 years | 35.05 | 36.64 | 96% |
Returns for 5 years | 30.88 | 39.11 | 79% |
Returns for 10 years | 66.16 | 71.18 | 93% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIB | 64.33 | 0.94 | +1.49% |
ProShares Ultra Nasdaq Biotechnology | |||
RYSE | 22.56 | 0.03 | +0.13% |
Cboe Vest 10 Yr Intst Rt Hdg ETF | |||
RIV | 11.96 | 0.01 | +0.08% |
RiverNorth Opportunities Fund | |||
USXF | 57.80 | -0.05 | -0.08% |
iShares® ESG Advanced MSCI USA ETF | |||
PSQO | 20.62 | -0.02 | -0.09% |
Palmer Square Credit Opportunities ETF |